High uptake of RSVpreF vaccine and nirsevimab was observed, with 64% of pregnant individuals and 70% of infants receiving ...

A study today in JAMA Network Open from the University of California, San Francisco (UCSF), shows a high uptake of respiratory syncytial virus (RSV) vaccine and the RSV-preventing monoclonal antibody ...

The RSV vaccine registered for use in pregnant women in Australia, Abrysvo, has been used since 2023 in the Americas and Europe. Real-world experience there shows it’s working well. For example ...

From February 3, pregnant women across the country will be eligible for a free RSV vaccine, Abrysvo, under the National Immunisation Program. This $174.5 million initiative promises to save lives ...

The Advisory Committee on Immunization Practices (ACIP) has backed the use of Abrysvo from 32 through 36 weeks of pregnancy to provide protection from RSV from birth through the first six months ...

The federal government is investing $174.5m to provide eligible pregnant women with the RSV vaccine, Abrysvo, under the National Immunisation Program from Monday. This new vaccine will help protect ...

In Britain, the RSV vaccine Abrysvo, made by Covid jab manufacturer Pfizer, is offered to adults aged 75 to 79 to help protect them against serious respiratory infections. Pregnant women past 28 ...

Health experts have warned a jab given to pregnant women and pensioners has ... labeling changes to the prescribing information for Abrysvo (Respiratory Syncytial Virus Vaccine) manufactured ...

Pregnant women across the Northern Territory now have free access to protection against a virus that is the leading cause of hospitalisation for babies. The federal government is investing $174.5m ...

The Australian Government is funding Pfizer’s Abrysvo for pregnant women and, in an unusual “hybrid” arrangement, states and territories are picking up the tab for Sanofi-Aventis ...